Distinct domains within APOBEC3G and APOBEC3F interact with separate regions of human immunodeficiency virus type 1 Vif.
Human APOBEC3G (A3G) and APOBEC3F (A3F) inhibit the replication of Vif-deficient human immunodeficiency virus type 1 (HIV-1). HIV-1 Vif overcomes these host restriction factors by binding to them and inducing their degradation. Thus, the Vif-A3G and Vif-A3F interactions are attractive targets for an...
| Main Authors: | , , , , |
|---|---|
| Format: | Journal article |
| Language: | English |
| Published: |
2009
|
| _version_ | 1797095384004165632 |
|---|---|
| author | Russell, R Smith, J Barr, R Bhattacharyya, D Pathak, V |
| author_facet | Russell, R Smith, J Barr, R Bhattacharyya, D Pathak, V |
| author_sort | Russell, R |
| collection | OXFORD |
| description | Human APOBEC3G (A3G) and APOBEC3F (A3F) inhibit the replication of Vif-deficient human immunodeficiency virus type 1 (HIV-1). HIV-1 Vif overcomes these host restriction factors by binding to them and inducing their degradation. Thus, the Vif-A3G and Vif-A3F interactions are attractive targets for antiviral drug development, as inhibiting these interactions could allow the host defense mechanism to control HIV-1 replication. Recently, it has been reported that amino acids 105 to 156 of A3G are involved in the interaction with Vif; however, to date, the region of A3F involved in Vif binding has not been identified. Using our previously reported Vif mutants that are capable of binding to only A3G (3G binder) or only A3F (3F binder), in conjunction with a series of A3G-A3F chimeras, we have now mapped the APOBEC3-Vif interaction domains. We found that the A3G domain that interacts with the Vif YRHHY region is located between amino acids 126 and 132 of A3G, which is consistent with the conclusions reported in previous studies. The A3F domain that interacts with the Vif DRMR region did not occur in the homologous domain but instead was located between amino acids 283 and 300 of A3F. These studies are the first to identify the A3F domain that interacts with the Vif DRMR region and show that distinct domains of A3G and A3F interact with different Vif regions. Pharmacological inhibition of either or both of these Vif-A3 interactions should prevent the degradation of the APOBEC3 proteins and could be used as a therapy against HIV-1. |
| first_indexed | 2024-03-07T04:27:03Z |
| format | Journal article |
| id | oxford-uuid:cd00cbde-7912-4734-9b3a-a8e3a2edbfec |
| institution | University of Oxford |
| language | English |
| last_indexed | 2024-03-07T04:27:03Z |
| publishDate | 2009 |
| record_format | dspace |
| spelling | oxford-uuid:cd00cbde-7912-4734-9b3a-a8e3a2edbfec2022-03-27T07:25:47ZDistinct domains within APOBEC3G and APOBEC3F interact with separate regions of human immunodeficiency virus type 1 Vif.Journal articlehttp://purl.org/coar/resource_type/c_dcae04bcuuid:cd00cbde-7912-4734-9b3a-a8e3a2edbfecEnglishSymplectic Elements at Oxford2009Russell, RSmith, JBarr, RBhattacharyya, DPathak, VHuman APOBEC3G (A3G) and APOBEC3F (A3F) inhibit the replication of Vif-deficient human immunodeficiency virus type 1 (HIV-1). HIV-1 Vif overcomes these host restriction factors by binding to them and inducing their degradation. Thus, the Vif-A3G and Vif-A3F interactions are attractive targets for antiviral drug development, as inhibiting these interactions could allow the host defense mechanism to control HIV-1 replication. Recently, it has been reported that amino acids 105 to 156 of A3G are involved in the interaction with Vif; however, to date, the region of A3F involved in Vif binding has not been identified. Using our previously reported Vif mutants that are capable of binding to only A3G (3G binder) or only A3F (3F binder), in conjunction with a series of A3G-A3F chimeras, we have now mapped the APOBEC3-Vif interaction domains. We found that the A3G domain that interacts with the Vif YRHHY region is located between amino acids 126 and 132 of A3G, which is consistent with the conclusions reported in previous studies. The A3F domain that interacts with the Vif DRMR region did not occur in the homologous domain but instead was located between amino acids 283 and 300 of A3F. These studies are the first to identify the A3F domain that interacts with the Vif DRMR region and show that distinct domains of A3G and A3F interact with different Vif regions. Pharmacological inhibition of either or both of these Vif-A3 interactions should prevent the degradation of the APOBEC3 proteins and could be used as a therapy against HIV-1. |
| spellingShingle | Russell, R Smith, J Barr, R Bhattacharyya, D Pathak, V Distinct domains within APOBEC3G and APOBEC3F interact with separate regions of human immunodeficiency virus type 1 Vif. |
| title | Distinct domains within APOBEC3G and APOBEC3F interact with separate regions of human immunodeficiency virus type 1 Vif. |
| title_full | Distinct domains within APOBEC3G and APOBEC3F interact with separate regions of human immunodeficiency virus type 1 Vif. |
| title_fullStr | Distinct domains within APOBEC3G and APOBEC3F interact with separate regions of human immunodeficiency virus type 1 Vif. |
| title_full_unstemmed | Distinct domains within APOBEC3G and APOBEC3F interact with separate regions of human immunodeficiency virus type 1 Vif. |
| title_short | Distinct domains within APOBEC3G and APOBEC3F interact with separate regions of human immunodeficiency virus type 1 Vif. |
| title_sort | distinct domains within apobec3g and apobec3f interact with separate regions of human immunodeficiency virus type 1 vif |
| work_keys_str_mv | AT russellr distinctdomainswithinapobec3gandapobec3finteractwithseparateregionsofhumanimmunodeficiencyvirustype1vif AT smithj distinctdomainswithinapobec3gandapobec3finteractwithseparateregionsofhumanimmunodeficiencyvirustype1vif AT barrr distinctdomainswithinapobec3gandapobec3finteractwithseparateregionsofhumanimmunodeficiencyvirustype1vif AT bhattacharyyad distinctdomainswithinapobec3gandapobec3finteractwithseparateregionsofhumanimmunodeficiencyvirustype1vif AT pathakv distinctdomainswithinapobec3gandapobec3finteractwithseparateregionsofhumanimmunodeficiencyvirustype1vif |